Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy
ACS Nano · 16.01.2024 · 18 (2) · 1582-1598
DOI: 10.1021/acsnano.3c09499 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 03.01.2024. Verfasst von Weiji Qin und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei 230011, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Photochemotherapy. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Anhui Medical University, National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Heterogeneity of the tumor microenvironment (TME) is primarily responsible for ineffective tumor treatment and uncontrolled tumor progression. Pyroptosis-based immunogenic cell death (ICD) therapy is an ideal strategy to overcome TME heterogeneity and obtain a satisfactory antitumor effect. However, the efficiency of current pyroptosis therapeutics, which mainly depends on a single endogenous or exogenous stimulus, is limited by the intrinsic pathological features of malignant cells. Thus, it is necessary to develop a synergistic strategy with a high tumor specificity and modulability. Herein, a synergistic nanoplatform is constructed by combining a neutrophil camouflaging shell and a self-synergistic reactive oxygen species (ROS) supplier-loaded polymer. The covered neutrophil membranes endow the nanoplatform with stealthy properties and facilitate sufficient tumor accumulation. Under laser irradiation, the photosensitizer (indocyanine green) exogenously triggers ROS generation and converts the laser irradiation into heat to upregulate NAD(P)H:quinone oxidoreductase 1, which further catalyzes β-Lapachone to self-produce sufficient endogenous ROS, resulting in amplified ICD outcomes. The results confirm that the continuously amplified ROS production not only eliminates the primary tumor but also concurrently enhances gasdermin E-mediated pyroptosis, initiates an ICD cascade, re-educates the heterogeneous TME, and promotes a systemic immune response to suppress distant tumors. Overall, this self-synergistic nanoplatform provides an efficient and durable method for redesigning the immune system for targeted tumor inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Anhui Medical University, Hefei 230011, P. R. China.
- Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei 230026, P. R. China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, P. R. China.
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.
ORCID-Profile: Xiaoyan He
Förderung
- Anhui Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Natural Science Foundation of Anhui Province
Zitieren
APA
Qin, W., Qiao, L., Wang, Q., Gao, M., Zhou, M., Sun, Q., Zhang, H., Yang, T., Shan, G., Yao, W., Yi, X., & He, X. (2024). Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy. ACS Nano, 18(2), 1582-1598. https://doi.org/10.1021/acsnano.3c09499
Vancouver
Qin W, Qiao L, Wang Q, Gao M, Zhou M, Sun Q, et al. Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy. ACS Nano. 2024;18(2):1582-1598. doi:10.1021/acsnano.3c09499
BibTeX
@article{Qin2024,
author = {Qin, Weiji and Qiao, Lei and Wang, Qian and Gao, Min and Zhou, Man and Sun, Qiuting and Zhang, Huiru and Yang, Tianhao and Shan, Guisong and Yao, Wanqing and Yi, Xiaoqing and He, Xiaoyan},
title = {Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {2},
pages = {1582--1598},
doi = {10.1021/acsnano.3c09499}
}
EUVIMED